FDA Approved Medical Products for:

Ovarian cancer

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Doxorubicin HCL liposome
Trade Name
(Manufacturer Name)
Doxil®
(Ortho Biotech)
Indication
The FDA has approved this product to be used in this manner.
Treatment of metastatic carcinoma of the ovary in patients with disease that is refractory to both paclitaxel- and platinium-based chemotherapy regimens. Refractory disease is defined as disease that has progressed while on treatment, or within 6 months
More Information about this product Drug Information Portal

Generic Name Amifostine
Trade Name
(Manufacturer Name)
Ethyol®
(Medimmune Oncology, Inc.)
Indication
The FDA has approved this product to be used in this manner.
To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
More Information about this product Drug Information Portal

Generic Name Altretamine
Trade Name
(Manufacturer Name)
Hexalen®
(Eisai)
Indication
The FDA has approved this product to be used in this manner.
Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Satumomab pendetide
Trade Name
(Manufacturer Name)
Oncoscint CR/OV
(Cytogen Corporation)
Indication
The FDA has approved this product to be used in this manner.
For determining the extent and location of extraphepatic malignant disease in patients with known colorectal and ovarian cancer.
More Information about this product Drug Information Portal